
Konamox CV 200mg/28.5mg Dry Syrup
Marketer
Konverge Healthcare Pvt Ltd
Salt Composition
Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
Overview Konamox CV 200mg/28.5mg Dry Syrup
Amoxicillin/clavulanate 200mg/28.5mg oral suspension is an antibiotic combating bacterial infections affecting the ears, nose, throat, respiratory system, teeth, skin, and urinary tract. Its effectiveness extends to bacteria resistant to other treatments, including multi-drug resistant tuberculosis. This suspension can be administered with or without food; however, co-administration with food improves absorption and minimizes stomach discomfort. The physician will determine the appropriate dosage (typically two to three times daily), based on the infection's severity, type, and the child's age and weight. Adhere strictly to the prescribed dosage, timing, and method. If vomiting occurs within 30 minutes, allow the child to rest and re-administer the dose; avoid doubling the dose if nearing the next scheduled administration. Potential side effects include nausea, vomiting, diarrhea, abdominal pain, and allergic reactions. Most side effects resolve spontaneously; however, persistent or concerning symptoms warrant immediate consultation with the child's doctor. Provide the physician with a complete medical history, including any allergies, cardiovascular issues, hematological disorders, congenital defects, respiratory problems, gastrointestinal conditions, dermatological issues, hepatic impairment, and renal dysfunction. This information aids in accurate dosage adjustments and comprehensive treatment planning.
Uses of Konamox CV 200mg/28.5mg Dry Syrup
Combating Drug-Resistant Tuberculosis and Bacterial Infections
Major Benefits of Konamox CV 200mg/28.5mg Dry Syrup:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always refer to the product label for preparation and administration details. Completely dissolve the powder in sterile water; shake thoroughly before use. Administer Konamox CV 200mg/28.5mg Dry Syrup with food.
Common Side effects of Konamox CV 200mg/28.5mg Dry Syrup:
- Abdominal pain
- Allergy
- Vomiting
- Nausea
- Diarrhea
- Mucocutaneous candidiasis
How to use Konamox CV 200mg/28.5mg Dry Syrup:
Administer this medication according to your physician's prescribed dosage and schedule. Always consult the product label for instructions prior to use. Completely dissolve the powder in sterile water. Shake thoroughly before consumption. Ingest Konamox CV 200mg/28.5mg Dry Syrup with food.
How Konamox CV 200mg/28.5mg Dry Syrup works:
Konamox CV Dry Syrup, containing 200mg amoxycillin and 28.5mg clavulanic acid, is a dual-action antibiotic. Amoxycillin disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Simultaneously, clavulanic acid neutralizes beta-lactamase, an enzyme produced by resistant bacteria that typically deactivates amoxycillin. This synergistic effect broadens the treatment spectrum of Konamox CV, making it effective against a wide range of infections.
SAFETY ADVICE
KidneyCAUTION
Patients with kidney impairment should use Konamox CV 200mg/28.5mg Dry Syrup cautiously, potentially requiring dosage modification. Consult a physician for appropriate dosing. Reduced dosages are also necessary for newborns and infants because of their immature kidney function.
LiverCAUTION
Patients with liver impairment should use Konamox CV 200mg/28.5mg Dry Syrup cautiously, potentially requiring dose modification. Consult a physician for guidance. Liver function should be regularly assessed during treatment.
What if you forget to take Konamox CV 200mg/28.5mg Dry Syrup :
Remember to administer the missed dose immediately upon recollection, unless your physician instructs differently. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate, and instead, adhere to the recommended dosage regimen.
Facts to Know About Konamox CV 200mg/28.5mg Dry Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-Infective Agents |
